Investment
Features
FeesSafety
Academy
More
Pluang+

Lawsuit probes Elauwit for misleading financial info after revenue error disclosure, stock drops 6.8%.

Market News
28 Sep 2026
PRNewsWire
View Source
Bearish
Lawsuit probes Elauwit for misleading financial info after revenue error disclosure, stock drops 6.8%.

Elauwit Connection, Inc. disclosed an error in its revenue recognition for the first nine months of 2025, leading to a restatement of financials and a 6.8% drop in its stock price. The Rosen Law Firm is investigating potential securities claims on behalf of shareholders, alleging the company issued materially misleading information. Investors who bought Elauwit securities may join a class action lawsuit seeking compensation without upfront costs. This legal action follows Elauwit's admission that a third-party accounting firm identified the error, which was not due to intentional misconduct by the company or its management.

Elauwit Connection, Inc. is the subject of a securities class action investigation. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 29, 2026 03:03 WIB: out of 150 priced US Technology stocks, 36 rose and 113 fell. Notable movers include ARM at USD 283.77 with a -8.56% change, TWLO at USD 275.52 with a -8.06% change, and AXTI at USD 73.11 with a -7.39% change.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
1 hour ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
1 hour ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
2 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
2 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App